Suchirayu owns a state-of-the-art multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The company has operations in North America, Asia, and Europe,
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
Filing marks first protein-based vaccine submitted to MHRA for authorization
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Subscribe To Our Newsletter & Stay Updated
